• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

DNDi 20th anniversary flags fly on Geneva’s Mont-Blanc bridge

Home > News

DNDi 20th anniversary flags fly on Geneva’s Mont-Blanc bridge

16 Oct 2023
  • English
    • English
    • Français

From Monday 16 October until Sunday 22 October, Geneva’s Mont-Blanc bridge will be adorned with flags commemorating DNDi’s 20th year of delivering the best science for the most neglected.

DNDi was established in 2003 when its seven founding partners* came together to respond to the frustration of doctors and health workers around the world faced with medicines that were ineffective, unsafe, unavailable, unaffordable – or that had never been developed at all.

Together with hundreds of partners and supporters who have joined us since, DNDi has delivered 12 new treatments for 6 deadly diseases – saving millions of lives.

Now operating from nine locations on five continents, DNDi has been present in Geneva since 2003 to engage with global health stakeholders on behalf of neglected patients. We have also received vital support for our mission from the Republic and Canton of Geneva from the start, for which we are deeply grateful.

Members of our Geneva team gathered in front of the bridge to mark this special occasion.
DNDi Flags flying on the Mont Blanc bridge in Geneva, Switzerland

* Our founding partners:

  • Indian Council of Medical Research
  • Institut Pasteur, France
  • Kenya Medical Research Institute
  • Médecins Sans Frontières (MSF)
  • Ministry of Health, Malaysia
  • Oswaldo Cruz Foundation, Brazil
  • World Health Organization Special Programme on Research and Training in Tropical Diseases (WHO/TDR)

Photo credits: Ariane Mawaffo-DNDi

Europe Switzerland

Read, watch, share

Loading...
Doctor speaking with a woman and her child
Press releases
22 Aug 2025

DNDi receives Japan’s Hideyo Noguchi Africa Prize 2025 for its work to develop new treatments for neglected diseases in Africa 

Dr Luis Pizarro delivering his acceptance address at the Hideyo Noguchi Africa Prize ceremony on 22 August 2025
News
22 Aug 2025

Acceptance address, Dr Luis Pizarro – Fifth Hideyo Noguchi Africa Prize Ceremony

Statements
21 Aug 2025

DNDi’s briefing note for the 75th Session of the World Health Organization Regional Committee for Africa

News
12 Aug 2025

DNDi calls for nominations for private sector Board member 

News
8 Aug 2025

Statement from DNDi on Kenya’s elimination of rhodesiense sleeping sickness as a public health problem 

News
5 Aug 2025

ADB and DNDi sign MoU to advance healthcare cooperation on neglected diseases in Asia and the Pacific

Press releases
23 Jul 2025

AN2 Therapeutics and DNDi collaborate on clinical development of promising new oral compound to treat chronic Chagas disease

Publications
15 Jul 2025

DNDi 2024 Annual Report

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License